Skip to main content
. 2020 Aug 20;268(2):455–466. doi: 10.1007/s00415-020-10158-1

Table 2.

Flow cytometry results the different subgroups of LE patients

Parameters Groups IAB+ (n = 41) AB− (n = 59) F
HLADR+  CD4+ T cells CSF (cells/ml) M/SD 105.8 ± 232.7 90.8 ± 153.6 0.150 n.s
HLADR+  CD4+ T cells CSF %# M/SD 0.19 ± 0.13 0.16 ± 0.1 3.059 (*)
HLADR+  CD4+ T cells PB (cells/ml) M/SD 50,647 ± 111,55 48,073 ± 117,81 0.931 n.s
HLADR+  CD4+ T cells PB %# M/SD 0.09 ± 0.06 0.06 ± 0.05 9.858 **
HLADR+  CD8+ T cells CSF (cells/ml) M/SD 47.1 ± 81.2 57.8 ± 70.4 0.484 n.s
HLADR+  CD8+ T cells CSF %# M/SD 0.53 ± 0.18 0.51 ± 0.19 0.266 n.s
HLADR+  CD8+ T cells PB (cells/ml) M/SD 32,77 ± 38,25 42,49 ± 86,80 0.442 n.s
HLADR+  CD8+ T cells PB %# M/SD 0.25 ± 0.20 0.16 ± 0.15 6.782 *
CD19+ B Cells CSF (cells/ml) M/SD 40.8 ± 214.9 6.04 ± 9.66 1.541 n.s
CD19+ B Cells PB (cells/ml) M/SD 140,54 ± 282,59 207.29 ± 458,00 0.674 n.s

M mean, SD standard deviation, n number, IAB+ intracellular auto-antibody positive, AB− auto-antibodies negative

#Corresponds to the following formula: x% = absolute numbers of HLADR+  CD4+ T-cells or HLADR+  CD8+ T-cells in PB or CSF (cells/ml) divided by absolute number CD4+ T-cells or CD8+ T-cells in PB or CSF (cells/ml)

n.s. not significant; (*)p < 0.1, *p < 0.05, **p < 0.01 ANOVA (F statistics) with post hoc analysis (LSD) or frequency tabulation with Chi2 test